Wentao Fang is the Chief of the Department of Thoracic Surgery and Division of Mediastinal Surgery at Shanghai Chest Hospital, a Chief Director of the Clinical Center for Esophageal Diseases, and a Professor at the School of Medicine of Shanghai Jiao Tong University. After having obtained his Doctoral Degree at Shanghai Jiao Tong University Medical School, he completed his residency in the Department of Thoracic Surgery, Shanghai Chest Hospital. He achieved his fellowship in the Division of Esophageal Surgery, National Cancer Center Hospital, Japan, and then became a Clinical Research Fellow in the Department of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School. He is a Member of the International Association for the Study of Lung Cancer (IASLC) and Staging and Prognostic Factors Committee (SPFC), a Program Committee Member of the World Conference on Lung Cancer (WCLC), Executive Committee Member of The European Association for Cardio-Thoracic Surgery (EACTS) and Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), among other. He is capable of performing a full range of thoracic procedures and has exclusive experience in minimally invasive (including Robotic) thoracic surgery, pulmonary resection for benign and malignant diseases, systemic lymph node dissection for esophageal cancer, anti-reflux procedures for GERD and thymectomy for thymoma and myasthenia gravis.
Wentao Fang is the Chief of the Department of Thoracic Surgery and Division of Mediastinal Surgery at Shanghai Chest Hospital, a Chief Director of the Clinical Center for Esophageal Diseases, and a Professor at the School of Medicine of Shanghai Jiao Tong University. After having obtained his Doctoral Degree at Shanghai Jiao Tong University Medical School, he completed his residency in the Department of Thoracic Surgery, Shanghai Chest Hospital. He achieved his fellowship in the Division of Esophageal Surgery, National Cancer Center Hospital, Japan, and then became a Clinical Research Fellow in the Department of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School. He is a Member of the International Association for the Study of Lung Cancer (IASLC) and Staging and Prognostic Factors Committee (SPFC), a Program Committee Member of the World Conference on Lung Cancer (WCLC), Executive Committee Member of The European Association for Cardio-Thoracic Surgery (EACTS) and Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), among other. He is capable of performing a full range of thoracic procedures and has exclusive experience in minimally invasive (including Robotic) thoracic surgery, pulmonary resection for benign and malignant diseases, systemic lymph node dissection for esophageal cancer, anti-reflux procedures for GERD and thymectomy for thymoma and myasthenia gravis.